Telix Pharmaceuticals TLX
NASDAQ TLX
$9.23 +0.20 (+2.21%)
As of: Oct 28, 2026 · 2:32 PM EDT

Telix Pharmaceuticals (TLX) Total Non-Current Liabilities (2023 - 2026)

Updated

Telix Pharmaceuticals' Total Non-Current Liabilities came in at $631.83 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Total Non-Current Liabilities was $516.99 million, unchanged from the prior year.

  • Going back by year, Total Non-Current Liabilities was $517.01 million in the year ended Dec 31, 2024 (+717.5%) and $63.24 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,147.89 Bn 1,116.48 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 654.22 Bn 574.08 Bn 17.30 Bn 102.65 Bn
3 AbbVie 508.68 Bn 481.79 Bn 12.70 Bn 106.45 Bn
4 Merck 347.00 Bn 301.38 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 302.29 Bn 275.53 Bn - -
6 Astrazeneca 263.02 Bn 236.71 Bn 12.86 Bn 33.91 Bn
7 Amgen 243.40 Bn 198.80 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 197.97 Bn 172.17 Bn 6.22 Bn 35.10 Bn
9 Pfizer 166.90 Bn 113.54 Bn 10.94 Bn 97.04 Bn
10 Telix Pharmaceuticals 3.12 Bn 2.08 Bn - 631.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 631.83 Mn
Dec 31, 2025 516.99 Mn
Dec 31, 2024 383.96 Mn
Dec 31, 2023 62.79 Mn
API Access

Telix Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TLX&period=max&api_key=YOUR_API_KEY